Close Menu

A DTC 'Flashpoint'

Some pharmacogenomic DTC tests that aim to assess a person's response to particular medicines may end up available only through a doctor's prescription, says New Scientist's Peter Aldhous. As FDA moves toward regulating the DTC genetic testing industry, the question of whether pharmacogenomic tests in particular should be regulated is "emerging as a flashpoint," Aldhous says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.